Towards a broader view of recovery.
It is estimated that tobacco use accounts for 25% of the total economic cost of illness in America.
Chemically dependent patients have a smoking rate that ranges from 80% to 95% in different studies, almost triple the national average.
Despite these staggering statistics, only a handful of chemical dependency treatment programs treat nicotine as an addictive drug and actively encourage their patients to quit.
Denial by treatment staff and fears in the Recovery community that Recovery would be jeopardized by quitting are two factors contributing to the reluctance to develop smoke-free programs and treat nicotine dependence.
The fear that patients would refuse admission to a facility that prohibits smoking and resistance from staff who smoke appear to be the major barriers to adopting a smoke-free policy.
Mots-clés Pascal : Tabagisme, Dépendance, Programme thérapeutique, Traitement, Sevrage toxique, Politique sanitaire, Organisation santé, Santé mentale, Prévention, Homme, Etude critique, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Tobacco smoking, Dependence, Therapeutic schedule, Treatment, Poison withdrawal, Health policy, Public health organization, Mental health, Prevention, Human, Critical study, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0470553
Code Inist : 002B18C05. Création : 199406.